AzTrials
AzTrials

MyopiaTO-SEENCT00978692

Toric Orthokeratology - Slowing Eye Elongation

A study testing Toric Orthokeratology lenses and Single-vision spectacles in people with Myopia and Astigmatism, run by The Hong Kong Polytechnic University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aims of this study are to investigate the effects of ortho-k for astigmatic and myopic reduction and myopic control in children, and the long term effects on corneal curvatures and biomechanics. Read more about this study

Who is it for?
Ages 6 to 12 yearsHealthy volunteers can take part
Conditions the study is for
Myopia, Astigmatism
What is being tested?
Toric Orthokeratology lenses and Single-vision spectacles
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteChina
Study dates
May 2008to Dec 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Myopia (refractive sphere): more than -0.50DS to -5.00DS
  • Astigmatism: with-the-rule astigmatism more than -1.25DC
  • Anisometropia: ≤ 1.50D in both refractive sphere
  • Best corrected monocular visual acuity: equal to or better than 0.10 in logMAR scale in both eyes
  • Availability for follow-up for at least 2 years

Who cannot join

  • Strabismus at distance or near
  • Contraindication for contact lens wear and orthokeratology (e.g. limbus to limbus corneal cylinder and dislocated corneal apex
  • Prior experience with the use of rigid lenses (including orthokeratology)
  • Prior experience with myopia control treatment (e.g. refractive therapy or progressive spectacles)
  • Systemic or ocular conditions which may affect contact lens wear (e.g. allergy and medication)
  • Systemic or ocular conditions which may affect refractive development (e.g. Down syndrome, ptosis)

Trial locations and contacts

1 site in 1 country.

China1 site
  • School of Optometry, The Hong KOng Polytechnic University

    Hong Kong SAR

Other trials in China

About this study

Official title: Toric Orthokeratology for Slowing Eye Elongation in Astigmatic Children

The aims of this study are to investigate the effects of ortho-k for astigmatic and myopic reduction and myopic control in children, and the long term effects on corneal curvatures and biomechanics.

Read the detailed description

Ortho-k has been shown to be effective in correcting low myopia but relatively ineffective for astigmatism, using spherical reverse geometry lens designs. Toric ortho-k lenses have been introduced in recent years but the efficacy for astigmatic reduction and for myopic control in children have not been confirmed. The mechanism of myopic reduction in ortho-k cannot be fully explained by changes to the anterior corneal curvatures. It is therefore possible that other corneal parameters such as posterior corneal curvature and corneal biomechanics may contribute to the mechanism.

The current study aims at investigating the efficacy of toric ortho-k lenses for correcting myopic astigmatism and for retarding myopic progression in children compared to children wearing single-vision spectacles. Long term changes to other corneal parameters such as posterior cornea curvatures, topographical corneal thickness, corneal hysteresis, corneal resistance factor, with and without ortho-k lens wear will also be investigated.

Conditions
Myopia, Astigmatism
Being tested
Toric Orthokeratology lenses, Single-vision spectacles
Keywords
Myopia, Astigmatism, Orthokeratology, Corneal thickness, Corneal curvatures, Corneal biomechanics
Medical subject headings
Myopia, Astigmatism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Toric Orthokeratology lensesDevice

    Also called corneal reshaping therapy

    Children wearing toric orthokeratology at night for correcting astigmatism and myopia will be the study group

  • Single-vision spectaclesDevice

    Also called glasses

    Children wearing single-vision spectacles in the daytime for correcting the refractive errors will serve as the control group

Study groups in NCT00978692
Study groupRoleWhat they receive
Toric orthokeratology lensesExperimentalChildren wearing toric ortho-k lenses at night for correcting astigmatism and myopia will be the study group
Receives: Device: Toric Orthokeratology lenses
Single-vision spectaclesOtherChildren wearing single-vision spectacles in the daytime for correcting the refractive error will be serve as control group
Receives: Device: Single-vision spectacles

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To determine the eyeball elongation in children wearing ortho-k lenses

    Measured: Before lens wear, 6, 12,18, 24 months after lens wear

Secondary outcomes (2)
  1. To determine the posterior corneal curvatures, topographic corneal thickness, corneal volume, corneal hysteresis and corneal resistance factor in a group of children and compare these parameters with the ortho-k children

    Measured: Before lens wear, 6, 12,18, 24 months after lens wear

  2. To investigative the efficacy of toric orthokeratology for correcting astigmatism and myopia

    Measured: Before lens wear, 6, 12,18, 24 months after lens wear

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2009 (estimated)
  2. Study startMay 2008
  3. Primary completionJul 2012
  4. Study completionDec 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00978692
Sponsor's protocol ID
H-ZG30
Acronym
TO-SEE
Status last verified
Feb 2016
First submitted
16 Sep 2009
Last updated
22 Feb 2016
Results posted
No
Data monitoring committee
No

Publications

  • Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci. 2013 Oct 3;54(10):6510-7. doi: 10.1167/iovs.13-12527.

    PubMed 24003088
  • Chen CC, Cheung SW, Cho P. Toric orthokeratology for highly astigmatic children. Optom Vis Sci. 2012 Jun;89(6):849-55. doi: 10.1097/OPX.0b013e318257c20f.

    PubMed 22561203
  • Chen C, Cho P. Toric orthokeratology for high myopic and astigmatic subjects for myopic control. Clin Exp Optom. 2012 Jan;95(1):103-8. doi: 10.1111/j.1444-0938.2011.00616.x. Epub 2011 Sep 5. No abstract available.

    PubMed 21895768

Questions about this trial

What is this clinical trial studying?

A study testing Toric Orthokeratology lenses and Single-vision spectacles in people with Myopia and Astigmatism, run by The Hong Kong Polytechnic University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Feb 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To determine the eyeball elongation in children wearing ortho-k lenses (time frame: Before lens wear, 6, 12,18, 24 months after lens wear). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00978692, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in